635 related articles for article (PubMed ID: 34956899)
1. Osteosarcoma and Metastasis.
Sheng G; Gao Y; Yang Y; Wu H
Front Oncol; 2021; 11():780264. PubMed ID: 34956899
[TBL] [Abstract][Full Text] [Related]
2. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.
Fan TM; Roberts RD; Lizardo MM
Front Oncol; 2020; 10():13. PubMed ID: 32082995
[TBL] [Abstract][Full Text] [Related]
3. The interaction between osteosarcoma and other cells in the bone microenvironment: From mechanism to clinical applications.
Zeng J; Peng Y; Wang D; Ayesha K; Chen S
Front Cell Dev Biol; 2023; 11():1123065. PubMed ID: 37206921
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review.
Zhou G; Shi X; Zhang J; Wu S; Zhao J
J Int Med Res; 2013 Feb; 41(1):1-12. PubMed ID: 23569124
[TBL] [Abstract][Full Text] [Related]
5. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs.
Chen C; Xie L; Ren T; Huang Y; Xu J; Guo W
Cancer Lett; 2021 Mar; 500():1-10. PubMed ID: 33359211
[TBL] [Abstract][Full Text] [Related]
7. Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis.
Nirala BK; Yamamichi T; Petrescu DI; Shafin TN; Yustein JT
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894474
[TBL] [Abstract][Full Text] [Related]
8. Bone Microenvironment and Osteosarcoma Metastasis.
Yang C; Tian Y; Zhao F; Chen Z; Su P; Li Y; Qian A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977425
[TBL] [Abstract][Full Text] [Related]
9. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
Lin Z; Xie X; Lu S; Liu T
Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
[TBL] [Abstract][Full Text] [Related]
10. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
11. Biology of osteogenic sarcoma.
Wang LL
Cancer J; 2005; 11(4):294-305. PubMed ID: 16197719
[TBL] [Abstract][Full Text] [Related]
12. Toward a drug development path that targets metastatic progression in osteosarcoma.
Khanna C; Fan TM; Gorlick R; Helman LJ; Kleinerman ES; Adamson PC; Houghton PJ; Tap WD; Welch DR; Steeg PS; Merlino G; Sorensen PH; Meltzer P; Kirsch DG; Janeway KA; Weigel B; Randall L; Withrow SJ; Paoloni M; Kaplan R; Teicher BA; Seibel NL; Smith M; Uren A; Patel SR; Trent J; Savage SA; Mirabello L; Reinke D; Barkaukas DA; Krailo M; Bernstein M
Clin Cancer Res; 2014 Aug; 20(16):4200-9. PubMed ID: 24803583
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Long Noncoding RNAs in Prostate Cancer, Osteosarcoma, and Metastasis.
Al-Shehri A; Bakhashab S
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831169
[TBL] [Abstract][Full Text] [Related]
14. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
Hughes DP
Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
[TBL] [Abstract][Full Text] [Related]
15. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
16. Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasis.
Fu Y; Liu Q; Bao Q; Wen J; Liu Z; Hu Y; He G; Peng C; Xu Y; Zhang W
Hereditas; 2021 Feb; 158(1):9. PubMed ID: 33593435
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma.
Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K
Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161
[TBL] [Abstract][Full Text] [Related]
18. Deciphering signaling networks in osteosarcoma pathobiology.
Adamopoulos C; Gargalionis AN; Basdra EK; Papavassiliou AG
Exp Biol Med (Maywood); 2016 Jun; 241(12):1296-305. PubMed ID: 27190271
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities.
Du X; Wei H; Zhang B; Wang B; Li Z; Pang LK; Zhao R; Yao W
Front Oncol; 2023; 13():1117867. PubMed ID: 37197432
[TBL] [Abstract][Full Text] [Related]
20. A bispecific antibody targeting IGF-IR and EGFR has tumor and metastasis suppressive activity in an orthotopic xenograft osteosarcoma mouse model.
Gvozdenovic A; Boro A; Born W; Muff R; Fuchs B
Am J Cancer Res; 2017; 7(7):1435-1449. PubMed ID: 28744395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
